Atlas Trials

The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa

Clinical trial NCT02018692 · NOT_YET_RECRUITING

Trial details

NCT number
NCT02018692
Sponsor
Sheba Medical Center
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Retinitis Pigmentosa
Start date
2026-03-01
Primary completion
2028-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.